SINOVAC BIOTECH LTD Net Income (Loss) Available to Common Stockholders, Diluted
SINOVAC BIOTECH LTD (SVA) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$59.68 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-06-05
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 12 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$59.68M 20-F · filed 2026-06-05 | |
| 2024-12-31 | $90.91M 20-F · filed 2026-06-05 | |
| 2023-12-31 | -$13.49M 20-F · filed 2026-06-05 | -$99.92M 20-F · filed 2024-04-29 |
| 2022-12-31 | $14.47M 20-F · filed 2026-04-30 | $113.87M 20-F · filed 2023-05-01 |
| 2021-12-31 | $8.12B 20-F · filed 2026-04-30 | $8.47B 20-F · filed 2022-04-29 |
| 2020-12-31 | $110.37M 20-F · filed 2023-05-01 | |
| 2019-12-31 | $44.93M 20-F · filed 2022-04-29 | |
| 2018-12-31 | $21.78M 20-F · filed 2021-04-22 | |
| 2017-12-31 | $25.81M 20-F · filed 2020-04-30 |